Key result
Pharmacotherapy, cardiac myosin modulators, and invasive strategies provide comprehensive management for HCM and LVOTO.
Why the study?
To provide an overview of current pharmacological and invasive strategies, as well as emerging therapies, in the management of hypertrophic cardiomyopathy.
Design
Review
Authors
Loading...
May guide individualized HCM-LVOTO decisions; leaves open comparative trials of myosin modulators versus invasive strategies.
This review provides a comprehensive overview of current and emerging pharmacological and invasive strategies for managing hypertrophic cardiomyopathy.
Dicorato et al. (2025) conducted a review in Hypertrophic cardiomyopathy (HCM). Pharmacological and invasive therapies was evaluated. Pharmacological therapies, cardiac myosin modulators, and invasive strategies provide comprehensive management options for hypertrophic cardiomyopathy and left ventricular outflow tract obstruction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: